FDA Inspection 1023652 — Patheon Softgels Inc

Patheon Softgels Inc — FEI 3001451366

The FDA completed an inspection of Patheon Softgels Inc on August 11, 2017 in High Point, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 11, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
High Point, NC (United States)